Patient
SITE015-0086
enrolled Phase IIIA Phase III, Randomized, Double-Blind Study of Torivumab Plus Chemotherapy Versus Placebo Plus Chemotherapy in Previously Untreated Advanced Non-Small Cell Lung Cancer · SITE015 (POL) (Dr. Ito)
consented 2025-12-02
Adverse events
5
Serious AEs
1
Open data queries
0
Luna dropout signal
—
not on Luna
Adverse events 5
Grade 1 Anaemia — outcome: RECOVERED/RESOLVED; onset 2023-02-17 (study day 247); relationship: NOT RELATED
Grade 3 Nausea — outcome: RECOVERED/RESOLVED; onset 2023-01-09 (study day 208); relationship: not assessed; serious criteria: hospitalization
Grade 2 Alopecia — outcome: RECOVERED/RESOLVED; onset 2022-11-12 (study day 150); relationship: NOT RELATED
Grade 1 Alopecia — outcome: RECOVERED/RESOLVED; onset 2022-11-08 (study day 146); relationship: RELATED
Grade 1 Decreased appetite — outcome: RECOVERED/RESOLVED; onset 2022-09-03 (study day 80); relationship: RELATED
Data queries 0
No data queries
The CDM sweep raises queries on inconsistent fields.
Luna engagement
This participant doesn't use Luna
Invite them from the site to track mood, adherence and check-ins.